menu Search
Tersia Pharma
Tersia Pharma

EUGIA AUROBINDO

Featured products of Eugia Aurobindo
Bortoma
Bortoma powd for inj 3.5 mg
bortezomib
Packing/Price
((lyo)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG01 - bortezomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Decinjet
Decinjet powd for conc for soln for infusion 50 mg
decitabine
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BC08 - decitabine : Belongs to the class of antimetabolites, pyrimidine analogues. Used in the treatment of cancer.
Fulvafit
Fulvafit soln for inj 250 mg/5 mL
fulvestrant
Packing/Price
2 × 1's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BA03 - fulvestrant : Belongs to the class of anti-estrogens. Used in treatment of neoplastic diseases.
Pexarite
Pexarite powd for conc for soln for infusion 100 mg
pemetrexed disodium hemipentahydrate
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Pexarite powd for conc for soln for infusion 500 mg
pemetrexed disodium hemipentahydrate
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Distributed by Tersia Pharma
Bortoma
Bortoma powd for inj 3.5 mg
bortezomib
Packing/Price
((lyo)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG01 - bortezomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Decinjet
Decinjet powd for conc for soln for infusion 50 mg
decitabine
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BC08 - decitabine : Belongs to the class of antimetabolites, pyrimidine analogues. Used in the treatment of cancer.
Fulvafit
Fulvafit soln for inj 250 mg/5 mL
fulvestrant
Packing/Price
2 × 1's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BA03 - fulvestrant : Belongs to the class of anti-estrogens. Used in treatment of neoplastic diseases.
Pexarite
Pexarite powd for conc for soln for infusion 100 mg
pemetrexed disodium hemipentahydrate
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Pexarite powd for conc for soln for infusion 500 mg
pemetrexed disodium hemipentahydrate
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Marketed by Tersia Pharma
Bortoma
Bortoma powd for inj 3.5 mg
bortezomib
Packing/Price
((lyo)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG01 - bortezomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Decinjet
Decinjet powd for conc for soln for infusion 50 mg
decitabine
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BC08 - decitabine : Belongs to the class of antimetabolites, pyrimidine analogues. Used in the treatment of cancer.
Fulvafit
Fulvafit soln for inj 250 mg/5 mL
fulvestrant
Packing/Price
2 × 1's
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BA03 - fulvestrant : Belongs to the class of anti-estrogens. Used in treatment of neoplastic diseases.
Pexarite
Pexarite powd for conc for soln for infusion 100 mg
pemetrexed disodium hemipentahydrate
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Pexarite powd for conc for soln for infusion 500 mg
pemetrexed disodium hemipentahydrate
Packing/Price
((lyo)) 1's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BA04 - pemetrexed : Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.